Annexon Bioscience's Seed VC Round

Annexon Bioscience raised a round of funding on August 22, 2011. Investors include F-Prime Capital.

Annexon Bioscience is developing a pipeline of classical complement pathway inhibitors focused on therapies for complement-mediated loss of nerve connections in the brain, as occurs in Alzheimer's dis…

Articles about Annexon Bioscience's Seed VC Round: